Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.

Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN.

Ann Surg Oncol. 2006 Jun;13(6):776-82. Epub 2006 Apr 17.

PMID:
16614878
2.

Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy.

Yang WT, Dryden MJ, Gwyn K, Whitman GJ, Theriault R.

Radiology. 2006 Apr;239(1):52-60. Epub 2006 Feb 16.

PMID:
16484353
3.

Breast carcinoma during pregnancy. International recommendations from an expert meeting.

Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Klingebiel T, Louwen F, Kaufmann M.

Cancer. 2006 Jan 15;106(2):237-46.

4.

Children exposed to chemotherapy in utero.

Gwyn K.

J Natl Cancer Inst Monogr. 2005;(34):69-71. Review.

PMID:
15784828
5.

Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer.

Gonzalez-Angulo AM, Walters RS, Carpenter RJ Jr, Ross MI, Perkins GH, Gwyn K, Theriault RL.

Clin Breast Cancer. 2004 Oct;5(4):317-9. Review.

PMID:
15507181
6.

Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma.

Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ.

Cancer. 2004 Apr 15;100(8):1595-604.

7.

Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.

Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.

Cancer. 2003 Sep 1;98(5):1055-60.

8.

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.

Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L.

Cancer. 2003 Jun 15;97(12):2960-71.

9.

Intention to pursue genetic testing for breast cancer among women due for screening mammography.

Gwyn K, Vernon SW, Conoley PM.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):96-102. Review.

10.

Breast cancer during pregnancy.

Gwyn KM, Theriault RL.

Curr Treat Options Oncol. 2000 Aug;1(3):239-43. Review.

PMID:
12057166
11.

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.

Cancer Res. 2002 Mar 15;62(6):1676-81.

12.

Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites.

Zhao H, Spitz MR, Gwyn KM, Wu X.

Mol Carcinog. 2002 Feb;33(2):99-104.

PMID:
11813302
13.

Conservative surgery and chemotherapy for breast carcinoma during pregnancy.

Kuerer HM, Gwyn K, Ames FC, Theriault RL.

Surgery. 2002 Jan;131(1):108-10. No abstract available.

PMID:
11812971
14.

Chemoprevention of colorectal cancer.

Gwyn K, Sinicrope FA.

Am J Gastroenterol. 2002 Jan;97(1):13-21. Review.

PMID:
11808936
15.

Multidisciplinary management of breast cancer concurrent with pregnancy.

Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM.

J Am Coll Surg. 2002 Jan;194(1):54-64. Review.

PMID:
11800340
16.

The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans.

Wu X, Gwyn K, Amos CI, Makan N, Hong WK, Spitz MR.

Carcinogenesis. 2001 Jun;22(6):923-8.

PMID:
11375900
17.

Breast cancer during pregnancy.

Gwyn K, Theriault R.

Oncology (Williston Park). 2001 Jan;15(1):39-46; discussion 46, 49-51. Review.

18.

Current perspectives on aromatase inhibitors in breast cancer.

Goss PE, Gwyn KM.

J Clin Oncol. 1994 Nov;12(11):2460-70. Review.

PMID:
7964964

Supplemental Content

Support Center